enoximone has been researched along with 2019 Novel Coronavirus Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beute, J; KleinJan, A | 1 |
| Cinelli, R; Ferro, B; Piras, AM; Roncucci, P; Vegnuti, L | 1 |
2 other study(ies) available for enoximone and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Phosphodiesterase-3 Inhibitor Enoximone in SARS-CoV-2 Infection.
Topics: Administration, Inhalation; COVID-19; Enoximone; Humans; Phosphoric Diester Hydrolases; SARS-CoV-2 | 2021 |
The Potential Role of Aerosolized Phosphodiesterase 3 Inhibitor Enoximone in the Management of Coronavirus Disease 2019 Hypoxemia: A Case Report.
Topics: Administration, Inhalation; Aerosols; Aged; COVID-19; COVID-19 Drug Treatment; Enoximone; Female; Humans; Hypoxia; Lung; Nebulizers and Vaporizers; Phosphodiesterase 3 Inhibitors; Pulmonary Circulation; Treatment Outcome | 2021 |